| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Chione Ltd is a 10% Owner at Karyopharm Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 17 sells.
Estimated insider holdings value: $61.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | ACRV Acrivon Therapeutics, Inc. | 10% Owner | Sell | 16 | $12.93 | $206.88 | - | -29.9% | -53.6% | |
| Jun 15, 2023 | ACRV Acrivon Therapeutics, Inc. | 10% Owner | Sell | 2,056 | $12.14 | $24,959.84 | - | -8.0% | -39.3% | |
| Jun 14, 2023 | ACRV Acrivon Therapeutics, Inc. | 10% Owner | Sell | 5,893 | $12.29 | $72,412.09 | - | -6.3% | -34.4% | |
| Nov 17, 2022 | ACRV Acrivon Therapeutics, Inc. | 10% Owner | Buy | 400,000 | $12.50 | $5,000,000.00 | +11.6% | +43.1% | -75.3% | |
| Feb 28, 2019 | KPTI Karyopharm Therapeutics Inc. | 10% Owner | Sell | 149,624 | $4.14 | $619,114.19 | -2.4% | - | - | |
| Feb 27, 2019 | KPTI Karyopharm Therapeutics Inc. | 10% Owner | Sell | 1,481,643 | $4.81 | $7,127,923.51 | -7.0% | - | - | |
| Sep 6, 2018 | KPTI Karyopharm Therapeutics Inc. | 10% Owner | Sell | 164,800 | $21.05 | $3,468,729.92 | -1.1% | - | - | |
| Sep 4, 2018 | KPTI Karyopharm Therapeutics Inc. | 10% Owner | Sell | 251,468 | $20.94 | $5,265,367.67 | -1.1% | - | - | |
| Aug 29, 2018 | KPTI Karyopharm Therapeutics Inc. | 10% Owner | Sell | 214,026 | $19.52 | $4,178,055.55 | -1.3% | - | - | |
| Aug 10, 2018 | KPTI Karyopharm Therapeutics Inc. | 10% Owner | Sell | 702 | $18.50 | $12,987.00 | - | - | - |